Browse the corpus
Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.
1 passage
REFERENCES Centers for Disease Control and Prevention (CDC), "Guidelines for the Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children," MMWR Recomm Rep , 2009, 58(RR-11):1-166. Available at file://aidsinfo.nih.gov/contentfiles/Pediatric_OI.pdf [PubMed 19730409 ] "Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents. Panel on Clinical Practices for Treatment of HIV Infection," June 18, 2008, MMWR Recomm Rep , 2009, 58(RR-4). Available at: file://www.aidsinfo.nih.gov . Haile LG and Flaherty JF, “Atovaquone: A Review,” Ann Pharmacother , 1993, 27(12):1488-94. [PubMed 8305784 ] Hughes W, Dorenbaum A, Yogev R, et al, “Phase I Safety and Pharmacokinetics Study of Micronized Atovaquone Human Immunodeficiency Virus-Infected Infants and Children. Pediatric AIDS Clinical Trials Group,” Antimicrob Agents Chemother , 1998, 42(6):1315-8. [PubMed 9624466 ] Hughes W, Leoung G, Kramer F, et al, “Comparison of Atovaquone (566C80) With Trimethoprim-Sulfamethoxazole to Treat Pneumocystis carinii Pneumonia in Patients With AIDS,” N Engl J Med , 1993, 328(21):1521-7. [PubMed 8479489 ] Red Book: 2009 Report of the Committee on Infectious Diseases , 28th ed, Pickering LK, ed, Elk Grove Village, IL: American Academy of Pediatrics, 2009. Topic 12856 Version 35.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [0504-125.39.66.147-AA4CF5E739-S244013.14]